Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing — Japanese experience

This publication has 13 references indexed in Scilit:

• Early Dynamics of Hepatitis C Virus in the Circulation of Chimpanzees with Experimental Infection
  Intervirology, 2005
• Occult hepatitis B virus infection: implications in transfusion
  Vox Sanguinis, 2004
• Titration of Hepatitis C Virus in Chimpanzees for Determining the Copy Number Required for Transmission
  Intervirology, 2004
• Sex- and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000
  Intervirology, 2004
• Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening
  Vox Sanguinis, 2003
• Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT
  Transfusion, 2002
• Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay
  Transfusion, 2001
• Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen
  Hepatology, 2000
• Correlation between Anti‐HBc Titers and HBV DNA in Blood Units without Detectable HBsAg
  Vox Sanguinis, 1992
• Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis
  The Lancet, 1991